Related references
Note: Only part of the references are listed.Interleukin-8 Mediates Resistance to Antiangiogenic Agent Sunitinib in Renal Cell Carcinoma
Dan Huang et al.
CANCER RESEARCH (2010)
Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma
Iris Helfrich et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Myeloid Cells in the Tumor Microenvironment: Modulation of Tumor Angiogenesis and Tumor Inflammation
Michael C. Schmid et al.
JOURNAL OF ONCOLOGY (2010)
The Novel Role of Tyrosine Kinase Inhibitor in the Reversal of Immune Suppression and Modulation of Tumor Microenvironment for Immune-Based Cancer Therapies
Junko Ozao-Choy et al.
CANCER RESEARCH (2009)
Sunitinib Inhibition of Stat3 Induces Renal Cell Carcinoma Tumor Cell Apoptosis and Reduces Immunosuppressive Cells
Hong Xin et al.
CANCER RESEARCH (2009)
Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
Jennifer S. Ko et al.
CLINICAL CANCER RESEARCH (2009)
CXCL12 enhances exogenous CD4+CD25+ T cell migration and prevents embryo loss in non-obese diabetic mice
Yi Lin et al.
FERTILITY AND STERILITY (2009)
Altering regulatory T cell function in cancer immunotherapy: a novel means to boost the efficacy of cancer vaccines
Jens Ruter et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Selectivity and therapeutic inhibition of kinases: to be or not to be?
Kamran Ghoreschi et al.
NATURE IMMUNOLOGY (2009)
Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines
Michael A. Morse et al.
BLOOD (2008)
Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis
Li Yang et al.
CANCER CELL (2008)
CD8+ T-cell responses against hemoglobin-β prevent solid tumor growth
Hideo Komita et al.
CANCER RESEARCH (2008)
Systemic Blockade of Transforming Growth Factor-β Signaling Augments the Efficacy of Immunogene Therapy
Samuel Kim et al.
CANCER RESEARCH (2008)
Tumor escape mechanism governed by myeloid-derived suppressor cells
Srinivas Nagaraj et al.
CANCER RESEARCH (2008)
Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients
James H. Finke et al.
CLINICAL CANCER RESEARCH (2008)
Ag-specific type 1 CD8 effector cells enhance methotrexate-mediated antitumor responses by modulating differentiated T cell localization, activation and chemokine production in established breast cancer
Mark J. Dobrzanski et al.
CLINICAL IMMUNOLOGY (2008)
Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
Pingyan Cheng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Stat6 signaling suppresses VLA-4 expression by CD8+ T cells and limits their ability to infiltrate tumor lesions in vivo
Kotaro Sasaki et al.
JOURNAL OF IMMUNOLOGY (2008)
Loss of suppressor of cytokine signaling 1 in helper T cells leads to defective Th17 differentiation by enhancing antagonistic effects of IFN-γ on STAT3 and Smads
Kentaro Tanaka et al.
JOURNAL OF IMMUNOLOGY (2008)
Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells
Pratima Sinha et al.
JOURNAL OF IMMUNOLOGY (2008)
The tumor microenvironment and its role in promoting tumor growth
T. L. Whiteside
ONCOGENE (2008)
Metastatic melanoma: Scientific rationale for sorafenib treatment and clinical results
Friederike Egberts et al.
ONKOLOGIE (2008)
Prolongation of cardiac and islet allograft survival by a blocking hamster anti-mouse CXCR3 monoclonal antibody
Ravindra Uppaluri et al.
TRANSPLANTATION (2008)
Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function
Ping-Ying Pan et al.
BLOOD (2008)
Failure at the effector phase: Immune barriers at the level of the melanoma tumor microenvironment
Thomas F. Gajewski
CLINICAL CANCER RESEARCH (2007)
CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers
Bo Huang et al.
CANCER LETTERS (2007)
CD4+FoxP3+regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo
Oliver M. Grauer et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis
Ilona Kryczek et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Targeted therapy for metastatic renal cell carcinoma
Robert J. Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Sunitinib in patients with metastatic renal cell carcinoma
Robert J. Motzer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Combinational FLt3 ligand and granulocyte macrophage colony-stimulating factor treatment promotes enhanced tumor infiltration by dendritic cells and antitumor CD8+ T-cell cross-priming but is ineffective as a therapy
Aklile Berhanu et al.
CANCER RESEARCH (2006)
Immune suppression in the tumor microenvironment
TF Gajewski et al.
JOURNAL OF IMMUNOTHERAPY (2006)
Agonist anti-GITR antibody enhances vaccine-induced CD8+ T-cell responses and tumor immunity
AD Cohen et al.
CANCER RESEARCH (2006)
Adoptive transfer of type 1 CTL mediates effective anti-central nervous system tumor response: Critical roles of IFN-inducible protein-10
F Nishimura et al.
CANCER RESEARCH (2006)
Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control
Fabrizio Vianello et al.
JOURNAL OF IMMUNOLOGY (2006)
Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host
B Huang et al.
CANCER RESEARCH (2006)
Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma
RJ Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems
PD Gregor et al.
VACCINE (2004)
Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals
LH Zou et al.
CANCER RESEARCH (2004)
Tumor-specific human CD4(+) regulatory T cells and their ligands: Implications for immunotherapy
HY Wang et al.
IMMUNITY (2004)
Role of angiogenesis in tumor growth and metastasis
J Folkman
SEMINARS IN ONCOLOGY (2002)
Overview of rationale and clinical trials with signal transduction inhibitors in lung cancer
CL Arteaga et al.
SEMINARS IN ONCOLOGY (2002)
The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3
P Loetscher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
DO11.10 and OT-II T cells recognize a C-terminal ovalbumin 323-339 epitope
JM Robertson et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
